QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway

QiShenYiQi pill (QSYQ), a traditional Chinese medicine, is used to treat cardiovascular diseases. However, the dose-effect relationship of its intervention in the reactive myocardial fibrosis is elusive. In this work, rat models of reactive myocardial fibrosis induced by partial abdominal aortic coa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Shichao, Yuan, Peng, Lu, Chunmiao, Dong, Jianping, Li, Meng, Qu, Fan, Zhu, Yaping, Zhang, Junping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950250/
https://www.ncbi.nlm.nih.gov/pubmed/33582656
http://dx.doi.org/10.18632/aging.202482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950250/
https://www.ncbi.nlm.nih.gov/pubmed/33582656
http://dx.doi.org/10.18632/aging.202482

Ejemplares similares